| Early T cell activation in the skin from patients with systemic sclerosis A Kalogerou, E Gelou, S Mountantonakis, L Settas, E Zafiriou, L Sakkas Annals of the rheumatic diseases 64 (8), 1233-1235, 2005 | 165 | 2005 |
| Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the … Y Vasilopoulos, M Manolika, E Zafiriou, T Sarafidou, V Bagiatis, ... Molecular diagnosis & therapy 16, 29-34, 2012 | 100 | 2012 |
| Objective biophysical findings in patients with sensitive skin. AV Roussaki-Schulze, E Zafiriou, D Nikoulis, E Klimi, E Rallis, E Zintzaras Drugs under experimental and clinical research 31, 17-24, 2005 | 92 | 2005 |
| Mini review: new treatments in psoriatic arthritis. focus on the IL-23/17 axis LI Sakkas, E Zafiriou, DP Bogdanos Frontiers in pharmacology 10, 872, 2019 | 88 | 2019 |
| Netherton syndrome: a genotype-phenotype review CA Sarri, A Roussaki-Schulze, Y Vasilopoulos, E Zafiriou, A Patsatsi, ... Molecular diagnosis & therapy 21, 137-152, 2017 | 85 | 2017 |
| IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17-and IFNγ-producing T cells A Mavropoulos, A Varna, E Zafiriou, C Liaskos, I Alexiou, ... Clinical Immunology 184, 33-41, 2017 | 82 | 2017 |
| Evaluation of cytokine serum levels in patients with plaque-type psoriasis. AV Roussaki-Schulze, C Kouskoukis, E Petinaki, E Klimi, E Zafiriou, ... International journal of clinical pharmacology research 25 (4), 169-173, 2005 | 74 | 2005 |
| Investigation of factors associated with health‐related quality of life and psychological distress in vitiligo K Bonotis, K Pantelis, S Karaoulanis, C Katsimaglis, M Papaliaga, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 14 (1), 45-48, 2016 | 65 | 2016 |
| Curcumin mediates attenuation of pro-inflammatory interferon γ and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant DΝ Skyvalidas, A Mavropoulos, S Tsiogkas, E Dardiotis, C Liaskos, ... Nutrition Research 75, 95-108, 2020 | 52 | 2020 |
| Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis A Mavropoulos, E Zafiriou, T Simopoulou, AG Brotis, C Liaskos, ... Rheumatology 58 (12), 2240-2250, 2019 | 48 | 2019 |
| Depression and obesity in patients with psoriasis and psoriatic arthritis: is IL-17-mediated immune dysregulation the connecting link? E Zafiriou, AI Daponte, V Siokas, C Tsigalou, E Dardiotis, DP Bogdanos Frontiers in Immunology 12, 699848, 2021 | 43 | 2021 |
| High serum levels of HIF-1α in psoriatic patients correlate with an over-expression of IL-6 Y Vasilopoulos, F Sourli, E Zafiriou, E Klimi, M Ioannou, Z Mamuris, ... Cytokine 62 (1), 38-39, 2013 | 38 | 2013 |
| A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population Y Vasilopoulos, C Sarri, E Zafiriou, A Patsatsi, C Stamatis, E Ntoumou, ... The Pharmacogenomics Journal 14 (6), 523-525, 2014 | 35 | 2014 |
| Increased HIF‐1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides M Ioannou, F Sourli, I Mylonis, S Barbanis, R Papamichali, E Kouvaras, ... Journal of cutaneous pathology 36 (12), 1255-1261, 2009 | 35 | 2009 |
| Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials X Theodoridis, MG Grammatikopoulou, EM Stamouli, P Talimtzi, ... Nutrition 82, 111024, 2021 | 32 | 2021 |
| Vaccination Coverage of the Elderly in Greece: A Cross‐Sectional Nationwide Study D Papagiannis, G Rachiotis, A Mariolis, E Zafiriou, KI Gourgoulianis Canadian Journal of Infectious Diseases and Medical Microbiology 2020 (1 …, 2020 | 31 | 2020 |
| Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and-9 in psoriatic plaques DP Vageli, A Exarchou, E Zafiriou, PG Doukas, S Doukas, ... Experimental and Therapeutic Medicine 10 (4), 1573-1577, 2015 | 31 | 2015 |
| Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis. AV Roussaki-Schulze, C Kouskoukis, E Klimi, E Zafiriou, A Galanos, ... Drugs under experimental and clinical research 31 (5-6), 169-174, 2005 | 23 | 2005 |
| Non-Melanoma Skin Cancer and Vitamin D: The “Lost Sunlight” Paradox and the Oxidative Stress Explanation E Karampinis, AM Aloizou, E Zafiriou, A Bargiota, Z Skaperda, D Kouretas, ... Antioxidants 12 (5), 1107, 2023 | 20 | 2023 |
| FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors E Mendrinou, A Patsatsi, E Zafiriou, D Papadopoulou, L Aggelou, C Sarri, ... The Pharmacogenomics Journal 17 (3), 237-241, 2017 | 19 | 2017 |
Roussaki-Schulze Angeliki-ViktoriaProfessor of Dermatology, Faculty of Medicine, University of ThessalyEmail verificata su med.uth.gr
